Novo's Ozempic faces scrutiny over potential link to rare eye disease
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's popular diabetes drug Ozempic to a rare sight-threatening eye condition.
Potential Eye Risks Linked to Popular Diabetes Drug Ozempic in Recent Danish Studies
Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). The Danish Medicines Agency has requested the European Pharmacovigilance Risk Assessment Committee to evaluate these findings,
Novo Nordisk To Invest DKK 8.5 Bln For New Production Facility In Denmark
Healthcare company Novo Nordisk A/S (NVO) announced Monday that it plans to invest 8.5 billion Danish kroner to establish a
Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark
By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the production of rare disease drugs,
Novo Nordisk to Invest $1.2 Bln in New Production Facility in Denmark
The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the rare disease area, such as haemophilia.
Novo Nordisk Invests DKK8.5 Bln in New Production Facility in Odense, Denmark
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Weight-loss Drugmaker Novo Nordisk Invests $1.2 Bn In New Factory In Denmark
Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was investing 8.5 billion kroner ($1.2 billion) to build a new factory in Denmark to produce drugs against rare diseases.
Novo Nordisk to park $1.2 billion in a new plant in Denmark for rare disease drugs
Danish pharma giant Novo Nordisk will make a significant investment of approximately $1.2 billion to construct a new production facilit
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...
People Aren't Using Ozempic 'Responsibly', Says Doctor
Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...
Ozempic Blinding-Link Potential Prompts Regulator to Seek Probe
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and ...
Becker's Hospital Review34m
Another study links Ozempic to rare vision loss
Study confirms link between Ozempic's active ingredient and low risk of vision loss. Ophthalmology organizations recommend continued use.
Ozempic could be linked to a common cause of sudden blindness, study finds
Novo Nordisk’s (NVO) blockbuster diabetes drug Ozempic may have a potential link with an eye condition that causes vision ...
Ozempic Killed Diet and Exercise
Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.
Ozempic Link to Rare Vision Loss Risk Confirmed in Study
Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that ...
For people who couldn’t get Ozempic or Wegovy, 2025 could be your year (if you can afford it)
It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...
The Ozempic Flip-Flop
A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...
Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.
Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney disease in ...